The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloablative fludarabine and busulfan regimen in myelofibrosis: Long term outcomes and analysis of prognostic factors.
 
Jacinth Joseph
No Relationships to Disclose
 
Denai R. Milton
No Relationships to Disclose
 
Julianne Chen
No Relationships to Disclose
 
Gheath Alatrash
No Relationships to Disclose
 
Amin Majid Alousi
Honoraria - Genentech; generon; kadmon
 
Qaiser Bashir
Consulting or Advisory Role - Amgen; Kite, a Gilead company; Purdue Pharma; Spectrum Pharmaceuticals; Takeda
Research Funding - Acrotech Biopharma; Celgene; Takeda (Inst)
 
Stefan O. Ciurea
No Relationships to Disclose
 
May Daher
No Relationships to Disclose
 
Jin Seon Im
No Relationships to Disclose
 
Rohtesh S. Mehta
No Relationships to Disclose
 
Betul Oran
Consulting or Advisory Role - Celgene
Research Funding - Arog; Astex Pharmaceuticals
 
Amanda Leigh Olson
No Relationships to Disclose
 
Neeraj Saini
No Relationships to Disclose
 
Samer Ali Srour
Consulting or Advisory Role - Celgene; Celgene
 
Borje Andersson
No Relationships to Disclose
 
Richard E. Champlin
No Relationships to Disclose
 
Uday R. Popat
Research Funding - Otsuka